An array of 60,000 antibodies for proteome-scale antibody generation and target discovery

A massively parallel array of monoclonal antibodies enables rapid antibody development and target discovery across species. Antibodies are essential for elucidating gene function. However, affordable technology for proteome-scale antibody generation does not exist. To address this, we developed Proteome Epitope Tag Antibody Library (PETAL) and its array. PETAL consists of 62,208 monoclonal antibodies (mAbs) against 15,199 peptides from diverse proteomes. PETAL harbors binders for a great multitude of proteins in nature due to antibody multispecificity, an intrinsic antibody feature. Distinctive combinations of 10,000 to 20,000 mAbs were found to target specific proteomes by array screening. Phenotype-specific mAb-protein pairs were found for maize and zebrafish samples. Immunofluorescence and flow cytometry mAbs for membrane proteins and chromatin immunoprecipitation–sequencing mAbs for transcription factors were identified from respective proteome-binding PETAL mAbs. Differential screening of cell surface proteomes of tumor and normal tissues identified internalizing tumor antigens for antibody-drug conjugates. By finding high-affinity mAbs at a fraction of current time and cost, PETAL enables proteome-scale antibody generation and target discovery.

[1]  Grahame Smith,et al.  The way forward , 2018, Reaching Net Zero.

[2]  R. Liddle,et al.  Piezo1 is a mechanically activated ion channel and mediates pressure induced pancreatitis , 2018, Nature Communications.

[3]  T. Nakao,et al.  The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapy , 2017, Nature Medicine.

[4]  Devin P. Sullivan,et al.  A subcellular map of the human proteome , 2017, Science.

[5]  C. Dumontet,et al.  Strategies and challenges for the next generation of antibody–drug conjugates , 2017, Nature Reviews Drug Discovery.

[6]  O. von Ahsen,et al.  Preclinical Antitumor Efficacy of BAY 1129980—a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody–Drug Conjugate for the Treatment of Non–Small Cell Lung Cancer , 2017, Molecular Cancer Therapeutics.

[7]  Yoshiaki Yamamoto,et al.  Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer. , 2016, Oncology reports.

[8]  Damian Szklarczyk,et al.  The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..

[9]  Emma Lundberg,et al.  A proposal for validation of antibodies , 2016, Nature Methods.

[10]  Chee-Hong Wong,et al.  Integrative epigenomic analysis reveals unique epigenetic signatures involved in unipotency of mouse female germline stem cells , 2016, Genome Biology.

[11]  M. Ohlsson,et al.  Technical Advances of the Recombinant Antibody Microarray Technology Platform for Clinical Immunoproteomics , 2016, PloS one.

[12]  José A. Dianes,et al.  2016 update of the PRIDE database and its related tools , 2016, Nucleic Acids Res..

[13]  Jeffrey R. Whiteaker,et al.  Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation , 2015, Nature Methods.

[14]  Mathias Uhlén,et al.  Charting the human proteome: Understanding disease using a tissue-based atlas , 2015 .

[15]  S. O’Brien,et al.  The Genome 10K Project: a way forward. , 2015, Annual review of animal biosciences.

[16]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[17]  G. Qin,et al.  Tomato nuclear proteome reveals the involvement of specific E2 ubiquitin-conjugating enzymes in fruit ripening , 2014, Genome Biology.

[18]  Li-xin Zhang,et al.  Isolation, cultivation and identification of human lung adenocarcinoma stem cells , 2014, Oncology letters.

[19]  N. Yuldasheva,et al.  Piezo1 integration of vascular architecture with physiological force , 2014, Nature.

[20]  M. Savageau,et al.  Relative Amino Acid Composition Signatures of Organisms and Environments , 2013, PloS one.

[21]  Timothy E. Reddy,et al.  Distinct properties of cell-type-specific and shared transcription factor binding sites. , 2013, Molecular cell.

[22]  Anushya Muruganujan,et al.  Large-scale gene function analysis with the PANTHER classification system , 2013, Nature Protocols.

[23]  Bao Liu,et al.  Multigene engineering of starch biosynthesis in maize endosperm increases the total starch content and the proportion of amylose , 2013, Transgenic Research.

[24]  Philippe C. Schmitter,et al.  European Disintegration?: A Way Forward? , 2012 .

[25]  M. Taussig,et al.  Affinity proteomics: the role of specific binding reagents in human proteome analysis , 2012, Expert review of proteomics.

[26]  G. Aguilera,et al.  Six Commercially Available Angiotensin II AT1 Receptor Antibodies are Non-specific , 2012, Cellular and Molecular Neurobiology.

[27]  M. Mann,et al.  Comparative Proteomic Analysis of Eleven Common Cell Lines Reveals Ubiquitous but Varying Expression of Most Proteins* , 2012, Molecular & Cellular Proteomics.

[28]  Véronique Giudicelli,et al.  IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. , 2011, Cold Spring Harbor protocols.

[29]  Philip Machanick,et al.  MEME-ChIP: motif analysis of large DNA datasets , 2011, Bioinform..

[30]  A. Crisanti,et al.  An antigen microarray immunoassay for multiplex screening of mouse monoclonal antibodies , 2010, Nature Protocols.

[31]  Vaughn V. Smider,et al.  Spatially addressed combinatorial protein libraries for recombinant antibody discovery and optimization , 2010, Nature Biotechnology.

[32]  Seung Hyun Kang,et al.  Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells , 2010, Nature Biotechnology.

[33]  P. Nilsson,et al.  Towards proteome scale antibody selections using phage display. , 2010, New biotechnology.

[34]  V. Orian-Rousseau.  CD44, a therapeutic target for metastasising tumours. , 2010, European journal of cancer.

[35]  Hiroyuki Kishi,et al.  A rapid and efficient single-cell manipulation method for screening antigen-specific antibody–secreting cells from human peripheral blood , 2009, Nature Medicine.

[36]  C. Wingren,et al.  Design of high-density antibody microarrays for disease proteomics: key technological issues. , 2009, Journal of proteomics.

[37]  M. Disatnik,et al.  Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target? , 2009, Trends in cardiovascular medicine.

[38]  T. Wieland,et al.  How reliable are G-protein-coupled receptor antibodies? , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[39]  E. Lundberg,et al.  A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies* , 2008, Molecular & Cellular Proteomics.

[40]  P. Arruda,et al.  Sugar levels modulate sorbitol dehydrogenase expression in maize , 2008, Plant Molecular Biology.

[41]  Marie-Paule Lefranc,et al.  IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis , 2008, Nucleic Acids Res..

[42]  Lisa Berglund,et al.  The epitope space of the human proteome , 2008, Protein science : a publication of the Protein Society.

[43]  Atif Shahab,et al.  Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. , 2007, Cell stem cell.

[44]  J. C. Love,et al.  A microengraving method for rapid selection of single cells producing antigen-specific antibodies , 2006, Nature Biotechnology.

[45]  R. Mariuzza.  Multiple paths to multispecificity. , 2006, Immunity.

[46]  P. Carter,et al.  Identification and validation of cell surface antigens for antibody targeting in oncology. , 2004, Endocrine-related cancer.

[47]  George Georgiou,et al.  Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Abner Louis Notkins,et al.  Polyreactivity of antibody molecules. , 2004, Trends in immunology.

[49]  Dan S. Tawfik,et al.  Antibody Multispecificity Mediated by Conformational Diversity , 2003, Science.

[50]  H. Steven Wiley,et al.  Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library , 2003, Nature Biotechnology.

[51]  I. Tomlinson,et al.  Antibody arrays for high-throughput screening of antibody–antigen interactions , 2000, Nature Biotechnology.

[52]  A. Plückthun,et al.  Ribosome display: an in vitro method for selection and evolution of antibodies from libraries. , 1999, Journal of immunological methods.

[53]  A. Kramer,et al.  Molecular Basis for the Binding Promiscuity of an Anti-p24 (HIV-1) Monoclonal Antibody , 1997, Cell.

[54]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[55]  W. Fair,et al.  Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. , 1993, Cancer research.

[56]  Jacob Cohen.  Statistical Power Analysis , 1992 .

[57]  E. Kabat,et al.  Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites. , 1991, Journal of immunology.

[58]  T. Clackson,et al.  Making antibody fragments using phage display libraries , 1991, Nature.

[59]  K. Hellström,et al.  Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens. , 1990, Cancer research.

[60]  Ruurd van der Zee,et al.  Prediction of sequential antigenic regions in proteins , 1985, FEBS letters.

[61]  K. R. Woods,et al.  Prediction of protein antigenic determinants from amino acid sequences. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[62]  D. Scheidegger,et al.  Production of monoclonal antibodies: strategy and tactics. , 1980, Journal of immunological methods.

[63]  G. Galfré,et al.  Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytes , 1977, Cell.

[64]  P. Y. Chou,et al.  Prediction of protein conformation. , 1974, Biochemistry.

[65]  C. Wingren.  Antibody-Based Proteomics. , 2016, Advances in experimental medicine and biology.

[66]  Joerg von Hagen,et al.  Cellular fractionation--mammalian cells. , 2013, Methods in enzymology.

[67]  Editor-in-Chief R. Seifert,et al.  Naunyn-Schmiedeberg's archives of pharmacology , 2005, Klinische Wochenschrift.

[68]  T. Hopp,et al.  Use of hydrophilicity plotting procedures to identify protein antigenic segments and other interaction sites. , 1989, Methods in enzymology.

[69]  R. Lerner,et al.  The chemistry and mechanism of antibody binding to protein antigens. , 1988, Advances in immunology.